D.E. Shaw & Co
LOXO

D.E. Shaw & Co’s Loxo Oncology, Inc LOXO Stock Holding History

D.E. Shaw & Co’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-19,434
Closed -$818K – 3638
2017
Q1 		$818K Sell
19,434
-27,742
-59% -$1.14M ﹤0.01% 2441
2016
Q4 		$1.51M Buy
+47,176
New +$1.21M ﹤0.01% 2203

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

D.E. Shaw & Co's LOXO Position: Q2 2017 in Review

D.E. Shaw & Co sold out of Loxo Oncology, Inc (LOXO) in Q2 2017, closing a stake of 19,434 shares — an estimated $818K sold.

D.E. Shaw & Co first reported a position in LOXO in Q4 2016 and held it in 2 quarters. The position peaked at $1.51M in Q4 2016. 129 funds tracked by Wall St. Rank hold LOXO as of Q2 2017.

  • D.E. Shaw & Co reported no remaining Loxo Oncology, Inc position as of Q2 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 19,434 Loxo Oncology, Inc shares in Q2 2017, an estimated $818K.
  • D.E. Shaw & Co first reported a position in Loxo Oncology, Inc in Q4 2016 and held it in 2 quarters.
  • D.E. Shaw & Co's Loxo Oncology, Inc position peaked at $1.51M in Q4 2016.
  • 129 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2017.

Based on D.E. Shaw & Co's 13F filing for Q2 2017, filed 14 Aug 2017.